TrialHuman reproduction (Oxford, England)2017

A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.

Ali Abbara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.